on 20 Jul 2021
Last Applicant/ Owned by
55234 Wendelsheim
DE
Serial Number
79292215 filed on 31st Jan 2020
Registration Number
6422358 registered on 20th Jul 2021
Correspondent Address
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell, & Berkowitz, PC
Ft. Lauderdale, FL 33301
United States
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Con Read More
Medical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor
N/A
N/A
Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services
N/A
N/A
Medical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor
N/A
N/A
Pharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes
N/A
N/A
Chemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science
N/A
N/A
No 79292215
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
26.09.13 -
Two squares
26.09.21 -
Squares that are completely or partially shaded
Status Date | Action Taken |
---|---|
11th Oct 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
26th Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
26th Feb 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
26th Feb 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
26th Feb 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
26th Feb 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
19th Dec 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
01st Dec 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
01st Dec 2021 | FINAL DISPOSITION PROCESSED |
20th Oct 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |